Literature DB >> 6494575

Predictive relevance for clinical outcome of in vitro sensitivity evaluated through antimetabolic assay.

R Silvestrini, O Sanfilippo, M G Daidone, N Zaffaroni.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6494575     DOI： 10.1007/978-3-642-82295-7_14

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  4 in total

1.  Comparison between an antimetabolic assay and a cytocidal assay for in vitro chemosensitivity testing of human tumors.

Authors:  E Grignolio; N Zaffaroni; R Villa; R Motta; R Silvestrini
Journal:  Cytotechnology       Date:  1987-10       Impact factor: 2.058

2.  An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrences.

Authors:  W Zoli; A Volpi; C Bonaguri; A Riccobon; S Savini; R Brizio; A Saragoni; L Medri; G A Marra; D Amadori
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.

Authors:  M G Daidone; R Silvestrini; N Zaffaroni; E Grignolio; F Landoni
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

4.  Flow cytometric analysis of human breast tumors and assessment of in vitro chemosensitivity by clonogenic assays.

Authors:  J Huot; J Aubin; F Goulet; R Goyette
Journal:  Cell Biol Toxicol       Date:  1990-01       Impact factor: 6.691
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.